Abstract
As melanoma starts spreading to various parts of the body from where it started, it is known as advanced melanoma. This study compares the results of the mixture and non-mixture cure models with the standard parametric models while estimating the long-term survival probability of the patients treated with nivolumab.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
